UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
ASSETS
Cash and cash equivalents	$ 9,752	$ 6,174
Restricted cash and equivalents	256,859	119,257
Finance receivables measured at fair value	2,960,375	2,722,662
Finance receivables	12,714	27,553
Less: Allowance for finance credit losses	(684)	(2,869)
Finance receivables, net	12,030	24,684
Furniture and equipment, net	1,192	1,372
Deferred tax assets, net	2,418	3,736
Other assets	43,916	25,861
Total assets	3,286,542	2,903,746
Liabilities
Accounts payable and accrued expenses	66,393	62,544
Warehouse lines of credit	82,175	234,025
Residual interest financing	99,079	49,875
Securitization trust debt	2,736,225	2,265,446
Subordinated renewable notes	22,356	17,188
Total liabilities	3,006,228	2,629,078
COMMITMENTS AND CONTINGENCIES
Shareholders' Equity
Common stock, no par value; authorized 75,000,000 shares; 21,304,643 and 21,174,856 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively	25,062	28,678
Retained earnings	257,119	247,857
Accumulated other comprehensive loss	(1,867)	(1,867)
Total shareholders' equity	280,314	274,668
Total liabilities and shareholders' equity	3,286,542	2,903,746
Preferred Stock [Member]
Shareholders' Equity
Preferred stock, value	0	0
Series A Preferred Stock [Member]
Shareholders' Equity
Preferred stock, value	0	0
Series B Preferred Stock [Member]
Shareholders' Equity
Preferred stock, value	$ 0	$ 0